ALETTA VANDERGRIFF: Open Payments
NPI 1912466475 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 25 payments from 8 companies in 2025. Trend: 2023 $189 · 2024 $229 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $260 |
| ABBVIE INC. | 4 | $193 |
| Otsuka America Pharmaceutical, Inc. | 1 | $114 |
| Boston Scientific Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Lundbeck LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, REXULTI, WATCHMAN FLX, MOUNJARO, GVOKE HYPOPEN, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
